Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Yu Liu

Showing results (121-130 of 296) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|December 25, 2016
Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics TreatmentMing-Han Chen, Ming-Huang Chen, Chun-Yu Liu, et al.
Biomedical Reports|August 20, 2025
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer samples with medium- and large-sized sequencing panels: A comparative study implicating treatment allocationsChi-Cheng Huang, Yi-Chen Yeh, Yi-Fang Tsai, et al.
Journal of the Chinese Medical Association : JCMA|June 20, 2025
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panelChi-Cheng Huang, Yi-Chen Yeh, Han-Fang Cheng, et al.
Cell Communication and Signaling : CCS|October 22, 2020
Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathwayTsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, et al.
Life Sciences|April 10, 2022
Overexpression of multiple epidermal growth factor like domains 11 rescues anoikis survival through tumor cells-platelet interaction in triple negative breast Cancer cellsChing-Po Huang, Yi-Fang Tsai, Yen-Shu Lin, et al.
Molecular Cancer Therapeutics|March 12, 2011
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2AKuen-Feng Chen, Hui-Chuan Yu, Chun-Yu Liu, et al.
Biochemical Pharmacology|May 15, 2012
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cellsKuen-Feng Chen, Jing-Ping Lin, Chung-Wai Shiau, et al.
International Journal of Medical Sciences|May 1, 2013
Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma l929 cellJing hua Yu, Chun yu Liu, Gui bin Zheng, et al.
Clinical and Experimental Rheumatology|August 2, 2014
Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritisMing-Han Chen, Po-Chun Liu, Chien-Wen Chang, et al.
Breast Cancer Research : BCR|August 14, 2013
Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cellsChun-Yu Liu, Ling-Ming Tseng, Jung-Chen Su, et al.
Pageof 30

Showing results (121-130 of 296) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|December 25, 2016
Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics TreatmentMing-Han Chen, Ming-Huang Chen, Chun-Yu Liu, et al.
Biomedical Reports|August 20, 2025
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer samples with medium- and large-sized sequencing panels: A comparative study implicating treatment allocationsChi-Cheng Huang, Yi-Chen Yeh, Yi-Fang Tsai, et al.
Journal of the Chinese Medical Association : JCMA|June 20, 2025
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panelChi-Cheng Huang, Yi-Chen Yeh, Han-Fang Cheng, et al.
Cell Communication and Signaling : CCS|October 22, 2020
Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathwayTsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, et al.
Life Sciences|April 10, 2022
Overexpression of multiple epidermal growth factor like domains 11 rescues anoikis survival through tumor cells-platelet interaction in triple negative breast Cancer cellsChing-Po Huang, Yi-Fang Tsai, Yen-Shu Lin, et al.
Molecular Cancer Therapeutics|March 12, 2011
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2AKuen-Feng Chen, Hui-Chuan Yu, Chun-Yu Liu, et al.
Biochemical Pharmacology|May 15, 2012
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cellsKuen-Feng Chen, Jing-Ping Lin, Chung-Wai Shiau, et al.
International Journal of Medical Sciences|May 1, 2013
Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma l929 cellJing hua Yu, Chun yu Liu, Gui bin Zheng, et al.
Clinical and Experimental Rheumatology|August 2, 2014
Decoy receptor 3 suppresses B cell functions and has a negative correlation with disease activity in rheumatoid arthritisMing-Han Chen, Po-Chun Liu, Chien-Wen Chang, et al.
Breast Cancer Research : BCR|August 14, 2013
Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cellsChun-Yu Liu, Ling-Ming Tseng, Jung-Chen Su, et al.
Pageof 30